Nanjing Vishee Medical Technology Co (SHSE:688580) Cash per Share : ¥11.64 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Nanjing Vishee Medical Technology Co's Cash per Share for the quarter that ended in Mar. 2024 was ¥11.64.

Nanjing Vishee Medical Technology Co Cash per Share Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co Cash per Share Chart

Nanjing Vishee Medical Technology Co Annual Data

Trend

Dec13

Dec14

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash per Share

Get a 7-Day Free Trial

3.41

14.28

12.99

12.02

Nanjing Vishee Medical Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash per Share	Get a 7-Day Free Trial															12.93	11.93	11.80	12.02	11.64

Nanjing Vishee Medical Technology Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Nanjing Vishee Medical Technology Co's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	1154.99	/	96.1
	=	12.02

Nanjing Vishee Medical Technology Co's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	1114.688	/	95.8
	=	11.64

Nanjing Vishee Medical Technology Co (SHSE:688580) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Nanjing Vishee Medical Technology Co Cash per Share Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012

Website

http://www.vishee.com

Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.

Executives

Huang He	Senior management, core technical personnel
Chou Kai	Senior management, core technical personnel
Zhong Yi Qun	senior management
Chen Li Li	Directors, senior managers
Zhang Hui	senior management
Gao Fei	Core technical personnel
Lian Qing Ming	Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines